Sponsor Pipeline

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
2
Recruiting
2
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06580236
Study of the Drug B11-FC (Botulism Treatment)		 overall status: Not Yet Recruiting → Unknown
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06815549 An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg… P. Aeruginosa Not Yet Recruiting
NCT04975737 Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac Tuberculosis Active, Not Recruiting
Phase 2
NCT06135350 Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM)… Gram Negative Pneumonia Recruiting
Phase 1
NCT07156864 "Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and… COVID-19 Not Yet Recruiting
NCT07184606 Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a… Safety and Pharmacokinetics Not Yet Recruiting
Not specified
NCT06162975 The Surveillance Clinical Study of Rickettsiosis Rickettsiosis Recruiting
Get alerts when Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free